Auxly Cannabis Group Inc. (TSX: XLY)
Health Care · Pharmaceuticals · CA
CA$3.12
-0.95% today · +39.3% 1Y
Auxly Cannabis Group Inc. (TSX: XLY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $232.86M and employs 446 people.
Over the last twelve months the share price has gained 39.3%, trading between 1.54 and 3.30.
Tweenvest scores Auxly Cannabis Group Inc. across four factors: quality 64/100, value 27/100, growth 88/100. Its strongest factor is growth.
XLY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $232.86M
- Revenue (TTM)
- $116.59M
- P/E
- 9.68
- EPS
- 0.32
- Dividend yield
- —
- Beta (5Y)
- 1.19
- 52-week high
- CA$3.30
- 52-week low
- CA$1.54
- Avg volume (3M)
- —
- Shares outstanding
- 103.24M
- Employees
- 446
- Next earnings
- —
About Auxly Cannabis Group Inc.
Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and wellness consumers. The company offers a wide array of cannabis formats under its distinct brands—KOLAB PROJECT, Dosecann, BACK FORTY, and Foray—including vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. Originally incorporated in 1987, the company was known as Cannabis Wheaton Income Corp. before officially changing its name to Auxly Cannabis Group Inc. in June 2018. It is headquartered in Toronto, Canada.
- ISIN
- CA05335P7039
- Founded
- 1987
- Listed since
- Jun 8, 2018
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.70 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.02 | -0.74% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.20 | +0.36% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.